RESTORATIVE THERAPIES, INC.

Restorative Therapies, Inc. specializes in the design, manufacturing, and delivery of advanced electromedical and surgical devices for clinical rehabilitation and prosthetic applications. Their core capabilities center on the development of stimulator systems, functional electrical stimulation (FES) cycles, and customized prosthetic interfaces, with deep technical expertise in multi-channel neuromuscular stimulation, patient-specific therapeutic device programming, and integrated medical electronics. The company demonstrates proficiency in FDA-regulated medical device manufacturing, including compliance with ISO 13485 quality standards and regulatory documentation for Class II devices. Key differentiators include their ability to rapidly prototype and deploy tailored stimulation platforms such as the RT300-SL and RT300-SLSA series, supporting both ambulatory and institutional rehabilitation workflows with precision control and real-time feedback systems. The company maintains a dominant and consistent relationship with the Department of Veterans Affairs, supplying mission-critical therapeutic and prosthetic equipment to VA medical centers nationwide. Their work supports veteran rehabilitation programs focused on mobility restoration, neurorecovery, and adaptive mobility solutions, often integrating with VA’s prosthetics and sensory aids network. Industry focus is firmly anchored in surgical appliance and supply manufacturing (NAICS 339113) and electromedical apparatus production (NAICS 334510), positioning Restorative Therapies as a niche provider of rehabilitative medical technology. They serve the growing demand for non-invasive neuromodulation devices and assistive mobility systems within the veteran and clinical care markets. As a small business structured as a 2L entity based in Nottingham, Maryland, Restorative Therapies operates without federal certifications but maintains a focused presence in the federal medical device procurement space, leveraging agile manufacturing and responsive R&D to meet VA-specific clinical requirements.